Keywords
Didroxyprogesterone
Progesterone
Meta-analysis
Submitted : 2021-07-03
Accepted : 2021-07-18
Published : 2021-08-02
Abstract
Objective: To systematically evaluate the efficacy and safety of didroxyprogesterone combined with progesterone in the treatment of luteal insufficiency abortion. Methods: We searched CNKI database, VIP database, Wanfang database, PubMed database, EMBASE database and Cochrane library database for literatures on the treatment of luteal insufficiency-induced abortion with didroxyprogesterone and progesterone. Meta-analysis was performed using Revman 5.3 software after literature extraction and further quality evaluation. Results: Ten randomized controlled trial-related articles that describe studies on a total of 1145 patients, 570 in the combination group and 575 in the control group, were included. The results of meta-analysis showed that combination therapy could improve the effective rate of fetal protection (OR = 0.14, 95% CI [0.07, 0.27], P < 0.00001). The safety of the combination group was significantly higher than that of the control group (OR = 3.09, 95% CI [1.13,8.48], P = 0.03). Conclusion: To sum up, compared with the control group, the combination of progesterone and progesterone is more effective and safer in the treatment of luteal insufficiency abortion. However, the sample size of the data is relatively small and the quality of the literature is low. This conclusion still needs to be further verified in high-quality randomized controlled trials that involve large samples.
References
Lou Y, 2019, Effect of Progesterone Combined with Progesterone on Hormone Levels in Patients with Threatened Abortion with Luteal Insufficiency. Journal of Practical Medical Technology, 26(8): 1060-1062.
Liu Y, 2018, Treatment of Threatened Abortion with Luteal Insufficiency by Didroxyprogesterone and Progesterone. Shenzhen Journal of Integrated Traditional Chinese and Western Medicine, 28(18): 105-106.
Chen X, 2017, Observation on the Effect of Didroxyprogesterone Combined with Progesterone in the Treatment of Threatened Abortion Caused by Luteal Insufficiency. Journal of Contemporary Medicine, 15(23): 145-146.
Xie X, Gou W, 2013, Obstetrics and Gynecology, 8th Edition, People’s Health Publishing House, Beijing, 48.
Zhu H, 2020, Analysis of the Effect of Progesterone Combined with Progesterone on Threatened Abortion with Luteal Insufficiency [J]. Chinese Journal of Medicine and Clinic, 20(9): 1525-1527.
Zhang C, 2018, The Application Value of Didroxyprogesterone in the Treatment of Threatened Abortion with Luteal Insufficiency. Journal of Contemporary Medicine, 16(23): 157-158.
Peng Y, 2018, Study on the Curative Effect of Dedrogesterone Combined with Progesterone in the Treatment of Luteal Insufficiency Abortion. China Modern Drug Application, 12(5): 133-134.
Xu Q, 2019, The Clinical Effect of Progesterone and Progesterone in the Treatment of Threatened Abortion with Luteal Insufficiency. Chinese Medical Guide, 17(33): 17.
Yang X, 2019, Clinical Effect of Oral Dydrogesterone Combined with Intramuscular Progesterone in the Treatment of Threatened Abortion with Luteal Insufficiency. Clinical Medical Research and Practice, 4(25): 101-103.
Wang Q, 2019, Effects of Progesterone Combined with Didroxyprogesterone on Hormone Levels and Cytokines in Patients with Luteal Insufficiency Induced Abortion. Chinese School Doctor, 33(3): 210-213.
Ouyang P, 2020, Clinical Efficacy of Progesterone Combined with Progesterone in the Treatment of Threatened Abortion with Luteal Insufficiency. Journal of Clinical Rational Drug Use, 13(3): 32-33.
Li LL, Yin C, Jiang L, 2017, Clinical Effect of Progesterone and Progesterone in the Treatment of Threatened Abortion with Luteal Insufficiency. Journal of Practical Gynecological Endocrinology (Electronic Edition), 4(10): 45 + 47.
Liang J, Luo F, Li X, et al., 2020, A Meta-analysis on Infertility Caused by Polycystic Ovary Syndrome by Bushen Huoxue Method. Journal of Hainan Medical College, 26(3): 219-225.
Fan L, Xue X, Zhang Y, et al., 2017, Clinical Study on the Treatment of Threatened Abortion with Luteal Insufficiency by Single or Combined Use of Progesterone and Progesterone. Drug Evaluation Research, 40(3): 381-384.